Proportion of isolates with decreased susceptibility or resistance in United States of America

United States of America: Proportion of isolates with decreased susceptibility or resistance was 0 in 2020. ◆ Volatile

Latest (2020)
0
Change on year
down 100.0%
World rank
13th
of 52 countries
All-time high
0.3841
in 2011
All-time low
0
in 2020
Years of data
11
2009–2020

Proportion of isolates with decreased susceptibility or resistance in United States of America, 2009–2020

00.10.20.30.42009201420202009: 0.2842010: 0.3342011: 0.3842012: 0.2732013: 0.052014: 0.1372015: 0.2722016: 0.2662017: 0.1982018: 0.1742020: 0

Source: World Health Organization, Global Health Observatory.

Analysis

United States of America recorded 0 for proportion of isolates with decreased susceptibility or resistance in 2020. That is the lowest value across all 11 years on record.

That represents a change of down 100.0% on the previous year and down 100.0% over ten years.

Over the whole period, proportion of isolates with decreased susceptibility or resistance in United States of America peaked at 0.3841 in 2011 and was at its lowest, 0, in 2020.

That places United States of America 13th out of 52 countries with data for 2020, putting it in the top quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Proportion of isolates with decreased susceptibility or resistance in United States of America, year by year

Annual values for Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP in United States of America, 2009 to 2020.
Year Value Change
2009 0.2842
2010 0.3337 +17.4%
2011 0.3841 +15.1%
2012 0.273 -28.9%
2013 0.0505 -81.5%
2014 0.1374 +172.4%
2015 0.272 +97.9%
2016 0.2664 -2.1%
2017 0.1976 -25.8%
2018 0.1744 -11.7%
2020 0 -100.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 0.2842 0.2842 0.2842 1
2010s 0.2321 0.0505 0.3841 9
2020s 0 0 0 1

Countries ranked near United States of America

  1. 10 Belgium 0.6 compare
  2. 11 New Zealand 0.1 compare
  3. 12 Australia 0.01 compare
  4. 13 Korea 0 compare
  5. 13 Argentina 0 compare
  6. 13 Croatia 0
  7. 13 Pakistan 0 compare
  8. 13 Ireland 0 compare
  9. 13 Chile 0
  10. 13 Poland 0
  11. 13 Latvia 0
  12. 13 Slovenia 0 compare
  13. 13 Malta 0
  14. 13 Thailand 0 compare
  15. 13 United Kingdom of Great Britain and Northern Ireland 0
  16. 13 Colombia 0
  17. 13 Cyprus 0
  18. 13 Spain 0 compare
  19. 13 Paraguay 0
  20. 13 Belarus 0
  21. 13 Philippines 0 compare
  22. 13 Slovakia 0
  23. 13 Sweden 0
  24. 13 Greece 0 compare
  25. 13 France 0
  26. 13 Denmark 0
  27. 13 South Africa 0
  28. 13 Norway 0
  29. 13 India 0 compare
  30. 13 Dominican Republic 0
  31. 13 Austria 0 compare
  32. 13 Peru 0 compare
  33. 13 Côte d'Ivoire 0
  34. 13 Germany 0 compare
  35. 13 Hungary 0
  36. 13 Iceland 0
  37. 13 Sri Lanka 0
  38. 13 Italy 0
  39. 13 Panama 0
  40. 13 Portugal 0
  41. 13 Netherlands 0
  42. 13 Estonia 0

See the full ranking of 52 places →

More health data for United States of America

All data for United States of America →

Frequently asked questions

What is proportion of isolates with decreased susceptibility or resistance in United States of America?
Proportion of isolates with decreased susceptibility or resistance in United States of America was 0 in 2020, according to World Health Organization, Global Health Observatory.
What is the highest proportion of isolates with decreased susceptibility or resistance recorded in United States of America?
The highest recorded value was 0.3841 in 2011.
What is the lowest proportion of isolates with decreased susceptibility or resistance recorded in United States of America?
The lowest recorded value was 0 in 2020.
How does United States of America rank for proportion of isolates with decreased susceptibility or resistance?
United States of America ranks 13th out of 52 countries with data for 2020.
Is proportion of isolates with decreased susceptibility or resistance rising or falling in United States of America?
Over the last ten years it is down 100.0%. The long-run trend across the full record is volatile.
Where does this United States of America data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 11 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Proportion of isolates with decreased susceptibility or resistance in United States of America. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 16 September 2026, from https://health.statizoid.com/stat/proportion-of-isolates-with-decreased-susceptibility-or-resistance-ds-r-to-ceftriaxone/united-states/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/proportion-of-isolates-with-decreased-susceptibility-or-resistance-ds-r-to-ceftriaxone/united-states/">Proportion of isolates with decreased susceptibility or resistance in United States of America</a> — Statizoid

About this data

Indicator
Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
52 places, 454 data points, 2009–2020
Last refreshed